TTrialPathMatch Me to Trials
← Back to trials
RecruitingCognitive ImpairmentHematologic NeoplasmsHematopoietic Cell Transplant

Cognitive Training Intervention and Attitudes Towards Genetics

Eligible age

21+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Sponsor: University of Alabama at Birmingham

You may qualify if…

  • ≥ 21 years old at time of allogeneic HCT performed at UAB
  • Outpatient and between 3 and 6 months post HCT
  • English speaking
  • Possess access to an internet-connected home computer

You may not qualify if…

  • History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
  • Participated in neuropsychological intervention within the past 6 months
  • History of color blindness

Where it's recruiting

Alabama

Birmingham

Source: ClinicalTrials.gov · NCT03094026 · last updated 2026-04-20

Cognitive Training Intervention and Attitudes Towards Genetics · TrialPath